Showing results (191-200 of 266) with videos related to

Sort By:
Pageof 27
Science (New York, N.Y.)|November 18, 1994
A central role of salicylic Acid in plant disease resistanceT P Delaney, S Uknes, B Vernooij, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 4, 2007
In vitro pharmacology of clinically used central nervous system-active drugs as inverse H(1) receptor agonistsR A Bakker, M W Nicholas, T T Smith, et al.
Pediatric Research|August 4, 2020
Genetic variant burden and adverse outcomes in pediatric cardiomyopathyDanielle S Burstein, J William Gaynor, Heather Griffis, et al.
The Journal of Biological Chemistry|June 3, 2000
Functional importance of the Ala(116)-Pro(136) region in the calcium-sensing receptor. Constitutive activity and inverse agonism in a family C G-protein-coupled receptorA A Jensen, T A Spalding, E S Burstein, et al.
Pediatric Cardiology|February 9, 2022
Safety and Feasibility of Exercise Rehabilitation in Children with Ventricular Assist DevicesDanielle S Burstein, Michael G McBride, Jonathan B Edelson, et al.
British Journal of Pharmacology|November 15, 2005
Characterization of the Mas-related gene family: structural and functional conservation of human and rhesus MrgX receptorsEthan S Burstein, Thomas R Ott, Michele Feddock, et al.
Plos One|March 22, 2013
Functional enhancement of AT1R potency in the presence of the TPαR is revealed by a comprehensive 7TM receptor co-expression screenJonas Tind Hansen, Christina Lyngsø, Tobias Speerschneider, et al.
Molecular Pharmacology|September 9, 2006
Structural requirements of transmembrane domain 3 for activation by the M1 muscarinic receptor agonists AC-42, AC-260584, clozapine, and N-desmethylclozapine: evidence for three distinct modes of receptor activationTracy A Spalding, Jian-Nong Ma, Thomas R Ott, et al.
Biochemical Pharmacology|September 12, 2001
Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoidL D Recht, R Salmonsen, R Rosetti, et al.
Circulation|January 1, 1995
Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?R A Kloner, T Shook, K Przyklenk, et al.
Pageof 27